Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Phase II Study Comparing CHOP vs Fractionated ICED in Transplant-Eligible, Previously Untreated Peripheral T-Cell Lymphoma
KCT0003046Phase 2Completed
- Sponsor
- Dong-A ST
- Start
- Sep 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide + doxorubicin + vincristine + prednisone in peripheral T-cell lymphoma (PTCL), sponsored by Dong-A ST. Started Sep 2015; status: completed.
02
Drugs
cyclophosphamide + doxorubicin + vincristine + prednisone
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on KCT0003046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003046.